🇺🇸 FDA
Pipeline program

Velusetrag

0099

Phase 2 small_molecule completed

Quick answer

Velusetrag for Gastroparesis is a Phase 2 program (small_molecule) at Theravance Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Theravance Biopharma
Indication
Gastroparesis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials